Lakefront Biotherapeutics (LKFT) Interest Expenses (2016 - 2020)

Lakefront Biotherapeutics (LKFT) has 5 years of Interest Expenses data on file, last reported at $1.1 million in Q1 2020.

• Interest Expenses for Q1 2020 came in at $1.1 million, up 312.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.0 (changed 0.0% YoY), and the FY2025 annual result was $1.2 million, up 23.64% from the prior year.
• Interest Expenses climbed to $1.1 million in Q1 2020 per LKFT's latest filing, from $632032.9 in the prior quarter.
• Over five years, Interest Expenses peaked at $58.8 million in Q1 2016 and troughed at -$16.8 million in Q2 2017.
• A 5-year average of $5.2 million and a median of $262457.9 in 2018 frame the typical range for Interest Expenses.
• On a YoY basis, Interest Expenses climbed as much as 1024.51% in 2019 and fell as far as 124.96% in 2019.
• A 5-year view of Interest Expenses shows it stood at $58.8 million in 2016, then plunged by 44.49% to $32.7 million in 2017, then plunged by 99.28% to $235127.7 in 2018, then jumped by 168.8% to $632032.9 in 2019, then soared by 75.89% to $1.1 million in 2020.
• Business Quant data shows LKFT's Interest Expenses at $1.1 million in Q1 2020, $632032.9 in Q4 2019, and $5.0 million in Q3 2019.